Overview
Yujiro Takai practices practicing medicine in Omorinaka, Japan.
Takai is highly rated in 9 conditions, according to our data. Their clinical expertise encompasses Acute Interstitial Pneumonia, Interstitial Lung Disease, Pulmonary Fibrosis, and Pneumonia.
They are actively involved in clinical research, co-authoring 33 peer reviewed articles.
Locations
Frequently Asked Questions about Yujiro Takai
Is Yujiro Takai a top-rated expert for Acute Interstitial Pneumonia?
MediFind is an objective health platform that identifies experts based on real-world data. Yujiro Takai is classified as an Advanced expert for Acute Interstitial Pneumonia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Interstitial Pneumonia
- EGFR Positive Lung Cancer
- Hypersensitivity Pneumonitis
- Idiopathic Pulmonary Fibrosis
- Interstitial Lung Disease
- Lung AdenocarcinomaTakai isAdvanced. Learn about Lung Adenocarcinoma.
- Lung CancerTakai isAdvanced. Learn about Lung Cancer.
- PneumoniaTakai isAdvanced. Learn about Pneumonia.
- Pulmonary FibrosisTakai isAdvanced. Learn about Pulmonary Fibrosis.
- Experienced
- Cerebral HypoxiaTakai isExperienced. Learn about Cerebral Hypoxia.
- EmphysemaTakai isExperienced. Learn about Emphysema.
- EmpyemaTakai isExperienced. Learn about Empyema.
- Lymphofollicular HyperplasiaTakai isExperienced. Learn about Lymphofollicular Hyperplasia.
- Mediastinal TumorTakai isExperienced. Learn about Mediastinal Tumor.
- Non-Small Cell Lung Cancer (NSCLC)
- Thymic Epithelial TumorTakai isExperienced. Learn about Thymic Epithelial Tumor.